Bluebird Bio
Now Genetix Biotherapeutics

Genetix Biotherapeutics is a privately held, commercial-stage company dedicated to delivering genetic therapies for patients with severe rare diseases.
Domain
Healthcare
Status
IPO’d/​Acquired
Acquisition Announcement Date
2025
IPO Date
2013
Stage of Initial Investment
Series D
Initial Investment Year
2012